Bovine serum albumin-mediated effects on colonic solubility, mucus permeation, and absorption of celecoxib
European Journal of Pharmaceutics and Biopharmaceutics · 2027-01 · 230 · 115265
DOI: 10.1016/j.ejpb.2026.115265 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2027-01. Verfasst von Suljovic D und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Copenhagen, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen, Denmark. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
Celecoxib was used as a model compound in fasted state simulated colonic fluid (FaSSCoF) to investigate equilibrium drug solubility (Seq), protein binding using rapid equilibrium dialysis (RED), flux and permeability (Papp) across porcine colonic mucus (PCM), and in vivo colonic absorption using a rat intracolonic instillation model. The primary focus was on the role of bovine serum albumin (BSA) as a solubilizing and binding constituent, while bile salts (sodium taurodeoxycholate, TDC) with lecithin and poloxamer 407 were included as comparative systems to evaluate how differences in solubilizer type influence celecoxib permeability and absorption. BSA demonstrated a pronounced solubilizing effect on celecoxib with a 1:1 M binding ratio, increasing the apparent Seq from 5.1 µg/mL to 92 µg/mL in FaSSCoF containing 15 mg/mL BSA. Under these conditions, diffusion across PCM increased approximately seven-fold compared with FaSSCoF without BSA, accompanied by a four-fold increase in colonic absorption in vivo. In contrast, when celecoxib concentration was maintained constant and BSA was subsequently added to FaSSCoF, diffusion across PCM decreased up to ten-fold at BSA concentrations of 1.5 mg/mL, accompanied by an approximately 30 % decrease in colonic absorption in vivo. This behavior is consistent with an increased BSA-bound fraction and a reduced free drug concentration available for transport. The addition of TDC with lecithin or poloxamer 407 similarly increased celecoxib diffusion across PCM and colonic absorption when celecoxib was dissolved at Seq in FaSSCoF, although no statistically significant differences were observed between the solubilizing systems. Overall, these findings demonstrate that solubilizing constituents in colonic fluids can substantially increase drug solubility, mucus permeation, and colonic absorption, highlighting the importance of accounting for protein-drug interactions when evaluating drug behavior in the colon.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Copenhagen, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen, Denmark.
- Gubra, Drug Profiling, Hørsholm, Denmark.
- Novo Nordisk, Oral Delivery Technologies, Måløv, Denmark.
- Ludwig-Maximilians-Universität München, Department of Pharmacy, Clinical Pharmacy and Pharmacotherapy, Butenandtstrasse 5-12, Munich, Germany.
- Bioneer:FARMA, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark.
- University of Copenhagen, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen, Denmark; Bioneer:FARMA, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark. Electronic address…
Förderung
- EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
Zitieren
APA
D, S., J, P., R, B., O, S. C., J, H., T, R., & A, M. (2027). Bovine serum albumin-mediated effects on colonic solubility, mucus permeation, and absorption of celecoxib. European Journal of Pharmaceutics and Biopharmaceutics, 230, 115265. https://doi.org/10.1016/j.ejpb.2026.115265
Vancouver
D S, J P, R B, O SC, J H, T R, et al. Bovine serum albumin-mediated effects on colonic solubility, mucus permeation, and absorption of celecoxib. European Journal of Pharmaceutics and Biopharmaceutics. 2027;230:115265. doi:10.1016/j.ejpb.2026.115265
BibTeX
@article{D2027,
author = {D, Suljovic and J, Plum and R, Berthelsen and O, Scherf-Clavel and J, Huhn and T, Rades and A, Müllertz},
title = {Bovine serum albumin-mediated effects on colonic solubility, mucus permeation, and absorption of celecoxib},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2027},
volume = {230},
pages = {115265},
doi = {10.1016/j.ejpb.2026.115265}
}
EUVIMED